Ming Guan Selected Research

Urogenital Diseases

4/2007	[Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
9/2004	Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.
7/2004	[Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Guan Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 02/2002
9	Inflammation (Inflammations) 01/2021 - 01/2013
9	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2010
8	Carcinogenesis 12/2019 - 01/2009
7	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2007
7	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 03/2007
7	Carcinoma (Carcinomatosis) 09/2017 - 03/2006
6	Lymphoma (Lymphomas) 08/2022 - 01/2013
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012 - 03/2011
5	Infections 01/2019 - 05/2005
5	Glioma (Gliomas) 09/2007 - 02/2002
4	Fibrosis (Cirrhosis) 01/2022 - 11/2014
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 11/2014
3	Wounds and Injuries (Trauma) 06/2022 - 08/2012
3	Testicular Neoplasms (Testicular Cancer) 01/2022 - 12/2020
3	Arthritis (Polyarthritis) 01/2022 - 04/2011
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2003
3	Thyroid Neoplasms (Thyroid Cancer) 12/2019 - 07/2015
3	Hyperplasia 09/2015 - 01/2009
3	Lymphatic Metastasis 04/2015 - 01/2010
3	Urogenital Diseases 04/2007 - 07/2004
3	Severe Acute Respiratory Syndrome 11/2004 - 03/2004
2	Hypersensitivity (Allergy) 01/2022 - 07/2018
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2020
2	Sepsis (Septicemia) 03/2021 - 01/2021
2	Tuberculosis (Tuberculoses) 01/2021 - 02/2011
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 01/2013
2	Primary Myelofibrosis (Myelosclerosis) 12/2019 - 07/2014
2	Follicular Adenocarcinoma 01/2019 - 07/2015
2	AIDS-Related Complex (ARC) 10/2017 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 12/2003
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2016 - 03/2006
2	Hypoxia (Hypoxemia) 12/2015 - 11/2003
2	Melanoma (Melanoma, Malignant) 04/2015 - 09/2012
2	Keloid 02/2015 - 07/2012
2	Atherosclerosis 12/2014 - 01/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2013 - 04/2005
2	Hematologic Neoplasms (Hematological Malignancy) 01/2011 - 10/2010
2	Hyperglycemia 02/2010 - 11/2003
1	Uveitis 07/2022

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
15	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
14	Biomarkers (Surrogate Marker)IBA 07/2022 - 06/2010
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2006
8	Long Noncoding RNAIBA 01/2021 - 11/2016
6	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2002
6	pigment epithelium-derived factorIBA 02/2013 - 11/2003
5	Phosphotransferases (Kinase)IBA 04/2018 - 07/2010
4	AntigensIBA 01/2022 - 11/2004
4	Biological ProductsIBA 12/2020 - 09/2004
4	Indicators and Reagents (Reagents)IBA 10/2020 - 10/2010
4	LipidsIBA 01/2020 - 12/2014
4	MethyltransferasesIBA 04/2011 - 03/2006
3	CollagenIBA 01/2022 - 11/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 01/2013
3	MicroRNAs (MicroRNA)IBA 10/2019 - 07/2015
3	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 11/2003
3	Small Interfering RNA (siRNA)IBA 10/2017 - 11/2013
3	EphrinsIBA 04/2016 - 01/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 11/2003
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2012 - 04/2011
3	EnzymesIBA 12/2010 - 03/2004
3	Recombinant ProteinsIBA 05/2005 - 03/2004
2	LigandsIBA 07/2022 - 10/2017
2	olaparibIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 11/2017
2	InterleukinsIBA 04/2021 - 01/2013
2	InflammasomesIBA 01/2020 - 09/2015
2	CateninsIBA 01/2020 - 04/2018
2	Allopurinol (Remid)FDA LinkGeneric 07/2018 - 02/2015
2	HLA-B Antigens (HLA-B)IBA 07/2018 - 02/2015
2	CytokinesIBA 11/2017 - 01/2013
2	EphA7 ReceptorIBA 10/2017 - 01/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 10/2016
2	Connective Tissue Growth FactorIBA 02/2015 - 07/2012
2	hydrogen sulfite (bisulfite)IBA 01/2015 - 06/2010
2	Decitabine FDA Link 01/2015 - 04/2011
2	Interleukin-22 (IL-22)IBA 01/2013 - 11/2011
2	Interleukin-8 (Interleukin 8)IBA 09/2012 - 02/2011
2	SugarsIBA 05/2012 - 12/2003
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2012 - 04/2011
2	Antinuclear AntibodiesIBA 01/2012 - 04/2011
2	A Kinase Anchor ProteinsIBA 04/2011 - 06/2010
2	AutoantibodiesIBA 04/2011 - 03/2011
2	Prostate-Specific Antigen (Semenogelase)IBA 02/2011 - 03/2006
2	Monoclonal AntibodiesIBA 05/2005 - 06/2002
2	AntibodiesIBA 05/2005 - 03/2004
2	ImmunosorbentsIBA 07/2004 - 03/2004
2	Thromboplastin (Tissue Factor)IBA 06/2002 - 02/2002
1	B-Cell Activating FactorIBA 07/2022

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2004
4	Drug Therapy (Chemotherapy) 08/2022 - 05/2005
3	Immunotherapy 01/2022 - 01/2013
3	Lasers (Laser) 04/2007 - 07/2004
2	Quantum Dots (Quantum Dot) 01/2022 - 01/2020
2	Photothermal Therapy 01/2022 - 12/2020
2	Anesthesia 12/2015 - 02/2012
2	Dye Lasers 02/2015 - 07/2012